Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0E1HY
|
|||
| Former ID |
DIB007831
|
|||
| Drug Name |
GPCR39 pepducins
|
|||
| Synonyms |
GPCR39 pepducins (lipopeptide, diabetes/obesity); GPCR39 pepducins (lipopeptide, diabetes/obesity), Anchor Therapeutics; GPCR39 pepducins (lipopeptide, diabetes/obesity), Anchor/Janssen; G-protein coupled receptor-39 modulators (lipopeptide, diabetes/obesity), Anchor Therapeutics; GPCR39 pepducins (lipopeptide, diabetes/obesity), Anchor Therapeutics/ Ortho-McNeil-Janssen
Click to Show/Hide
|
|||
| Indication | Diabetic complication [ICD-11: 5A2Y; ICD-9: 253.5, 588.1] | Investigative | [1] | |
| Company |
Anchor Therapeutics Inc
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | G-protein coupled receptor 39 (GPR39) | Target Info | Modulator | [1] |
| Reactome | Class A/1 (Rhodopsin-like receptors) | |||
| WikiPathways | GPCRs, Class A Rhodopsin-like | |||
| GPCR ligand binding | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 105). | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.